33
/pt/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512564
319423
2
Public Timelines
FAQ Receber premium

1 jan 2014 ano - Pembrolizumab

Descrição:

Pembrolizumab is approved for advanced melanoma treatment by the FDA. This monoclonal antibody blocks a protein called PD1's activity on immune cells, which increases the strength of the immune response to cancer.

Adicionado na linha do tempo:

14 nov 2019
0
0
302

Data:

1 jan 2014 ano
Agora
~ 11 years ago